A Phase 1b Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of an Investigational Microbiome Therapeutic, SER-155, in Adults Undergoing Hematopoietic Stem Cell Transplantation
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10532-10533
10.1182/blood-2022-162386